Cargando…

Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which there is no cure. Huperzine A (HupA) is a natural inhibitor of acetylcholinesterase (AChE) derived from the Chinese folk medicine Huperzia serrata (Qian Ceng Ta). It is a licensed anti-AD drug in China and is available as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Zhong Ming, Ke, Ya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137276/ https://www.ncbi.nlm.nih.gov/pubmed/25191267 http://dx.doi.org/10.3389/fnagi.2014.00216

Ejemplares similares

Disease-Modifying Activity of Huperzine A on Alzheimer’s Disease: Evidence from Preclinical Studies on Rodent Models
por: Yan, Ye-Piao, et al.
Publicado: (2022)

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: Friedli, María Jesús, et al.
Publicado: (2021)

Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease
por: Yan, Qinying, et al.
Publicado: (2020)

Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis
por: Xing, Shu-huai, et al.
Publicado: (2014)

Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Yang, Guoyan, et al.
Publicado: (2013)

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng, Qingqing, et al.
Publicado: (2018)

Intravitreal injection of Huperzine A promotes retinal ganglion cells survival and axonal regeneration after optic nerve crush
por: Zhou, Lai-Yang, et al.
Publicado: (2023)

Integration of System Biology Tools to Investigate Huperzine A as an Anti-Alzheimer Agent
por: Khanal, Pukar, et al.
Publicado: (2021)

The pharmacology and therapeutic potential of (−)-huperzine A
por: Tun, Maung Kyaw Moe, et al.
Publicado: (2012)

Huperzine A and Huperzine B Production by Prothallus Cultures of Huperzia selago (L.) Bernh. ex Schrank et Mart
por: Szypuła, Wojciech J., et al.
Publicado: (2020)

Examining the Interactome of Huperzine A by Magnetic Biopanning
por: Guo, Wei, et al.
Publicado: (2012)

Modifiable Risk Factors for Alzheimer’s Disease
por: Edwards III, George A., et al.
Publicado: (2019)

Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake
por: Li, Fang, et al.
Publicado: (2017)

Histone Acetylation Modifiers in the Pathogenesis of Alzheimer’s Disease
por: Lu, Xi, et al.
Publicado: (2015)

Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats
por: Mao, Xiao-Yuan, et al.
Publicado: (2014)

The complete mitochondrial genome of huperzine A-producing endophytic fungus Penicillium polonicum
por: Kang, Xincong, et al.
Publicado: (2016)

Synergistic Effect and Mechanism of Cineole and Terpineol on In-vitro Transdermal Delivery of Huperzine A from Microemulsions
por: Shi, Jun, et al.
Publicado: (2013)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study
por: Hu, Xiao-na, et al.
Publicado: (2018)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection
por: Yang, Xin, et al.
Publicado: (2020)

Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
por: Peng, Yong, et al.
Publicado: (2023)

Transfer learning-based modified inception model for the diagnosis of Alzheimer's disease
por: Sharma, Sarang, et al.
Publicado: (2022)

Huperzine A-Liposomes Efficiently Improve Neural Injury in the Hippocampus of Mice with Chronic Intermittent Hypoxia
por: Yang, Xin-Yue, et al.
Publicado: (2023)

The effects of huperzine A on gastrointestinal acetylcholinesterase activity and motility after single and multiple dosing in mice
por: ZHANG, LEIMING, et al.
Publicado: (2013)

Effects of huperzine A on hippocampal inflammatory response and neurotrophic factors in aged rats after anesthesia
por: Cai, Yi, et al.
Publicado: (2020)

Huperzia serrata Extract ‘NSP01’ With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols
por: Callizot, N., et al.
Publicado: (2021)

Calcium and Neurogenesis in Alzheimer's Disease
por: Wang, Jun Ming, et al.
Publicado: (2010)

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
por: Gong, Cheng-Xin, et al.
Publicado: (2022)

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

In Silico-Guided Rational Drug Design and Semi-synthesis of C(2)-Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitors
por: Anukanon, Shisanupong, et al.
Publicado: (2021)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Ethanol and Methanol Can Improve Huperzine A Production from Endophytic Colletotrichum gloeosporioides ES026
por: Zhao, Xin-Mei, et al.
Publicado: (2013)

Ultrastructural mitochondria changes in perihematomal brain and neuroprotective effects of Huperzine A after acute intracerebral hemorrhage
por: Lu, Haiying, et al.
Publicado: (2015)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches
por: Shamsi, Anas, et al.
Publicado: (2022)

In Vitro Propagation, Huperzine A Content and Antioxidant Activity of Three Genotypic Huperzia serrata
por: Yang, Yan, et al.
Publicado: (2021)

Mechanistic Insight into the Binding of Huperzine a with Human Transferrin: Computational, Spectroscopic and Calorimetric Approaches
por: Atiya, Akhtar, et al.
Publicado: (2022)

Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022)

Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy
por: Casillas-Espinosa, Pablo M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2qgqq24ce8nf6fjmprefr347em